CureVac (CVAC) Short Interest Ratio & Short Volume → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free CVAC Stock Alerts $3.49 +0.01 (+0.29%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability CureVac Short Interest DataCurrent Short Volume4,390,000 sharesPrevious Short Volume4,190,000 sharesChange Vs. Previous Month+4.77%Dollar Volume Sold Short$11.06 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 30, 2024Outstanding Shares223,880,000 sharesFloat Size91,600,000 sharesShort Percent of Float4.79%Today's Trading Volume2,390,095 sharesAverage Trading Volume677,021 sharesToday's Volume Vs. Average353% Short Selling CureVac ? Sign up to receive the latest short interest report for CureVac and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCVAC Short Interest Over TimeCVAC Days to Cover Over TimeCVAC Percentage of Float Shorted Over Time Ad True Market InsidersMy #1 investment for 2024It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024. CureVac Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,390,000 shares $11.06 million +4.8%4.8%5.5 $2.52 4/15/20244,190,000 shares $11.10 million -16.4%4.6%5.3 $2.65 3/31/20245,010,000 shares $15.18 million +3.1%5.5%6.1 $3.03 3/15/20244,860,000 shares $16.04 million +10.7%5.3%5.5 $3.30 2/29/20244,390,000 shares $15.01 million +3.1%4.8%3.5 $3.42 2/15/20244,260,000 shares $14.74 million +2.9%4.7%3.6 $3.46 Get the Latest News and Ratings for CVAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CureVac and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,140,000 shares $14.86 million -1.2%4.5%3.7 $3.59 1/15/20244,190,000 shares $16.26 million +1.7%4.6%4 $3.88 12/31/20234,120,000 shares $17.35 million +9.9%4.5%4.1 $4.21 12/15/20233,750,000 shares $22.95 million -11.6%4.1%3.7 $6.12 11/30/20234,240,000 shares $22.90 million +2.7%4.6%8.8 $5.40 11/15/20234,130,000 shares $22.84 million -3.7%4.5%9.5 $5.53 10/31/20234,290,000 shares $22.74 million +1.7%4.7%9.3 $5.30 10/15/20234,220,000 shares $25.02 million +1.0%4.6%9.6 $5.93 9/30/20234,180,000 shares $28.55 million -8.5%4.6%9.3 $6.83 9/15/20234,570,000 shares $36.61 million -7.7%5.0%10.8 $8.01 8/31/20234,950,000 shares $44.20 million +2.1%5.4%8.8 $8.93 8/15/20234,850,000 shares $44.86 million +0.2%5.3%7.5 $9.25 7/31/20234,840,000 shares $44.92 million -1.6%5.3%7.2 $9.28 7/15/20234,920,000 shares $48.66 million +12.3%5.4%7.1 $9.89 6/30/20234,380,000 shares $45.64 million +5.0%4.8%6.6 $10.42 6/15/20234,170,000 shares $41.45 million -0.7%4.5%6.7 $9.94 5/31/20234,200,000 shares $40.53 million -2.6%4.5%8.1 $9.65 5/15/20234,310,000 shares $38.40 million +19.4%4.6%7.7 $8.91 4/30/20233,610,000 shares $26.61 million -11.5%3.9%4.9 $7.37 4/15/20234,080,000 shares $31.78 million -0.7%4.5%5.1 $7.79 3/31/20234,110,000 shares $28.65 million +13.5%4.5%3.5 $6.97 3/15/20233,620,000 shares $25.34 million +2.8%4.0%3 $7.00 2/28/20233,520,000 shares $30.41 million +11.0%3.9%2.9 $8.64 2/15/20233,170,000 shares $28.09 million -26.3%4.8%2.7 $8.86 1/31/20234,300,000 shares $46.18 million No Change7.6%3.8 $10.74 1/15/20234,300,000 shares $44.03 million +75.5%7.6%5 $10.24 12/30/20222,450,000 shares $14.77 million +20.7%4.4%3.8 $6.03 12/15/20222,030,000 shares $13.74 million -2.9%3.6%4.8 $6.77 11/30/20222,090,000 shares $15.15 million -7.5%2.9%6.1 $7.25 11/15/20222,260,000 shares $18.24 million -13.4%3.2%6.7 $8.07 10/31/20222,610,000 shares $19.00 million -3.0%4.8%8.7 $7.28 10/15/20222,690,000 shares $20.23 million -5.9%4.9%8.6 $7.52 9/30/20222,860,000 shares $22.54 million -17.3%5.3%8.7 $7.88 9/15/20223,460,000 shares $33.35 million +5.2%6.4%7.1 $9.64Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. CVAC Short Interest - Frequently Asked Questions What is CureVac's current short interest? Short interest is the volume of CureVac shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,390,000 shares of CVAC short. 4.79% of CureVac's shares are currently sold short. Learn More on CureVac's current short interest. What is a good short interest ratio for CureVac? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CVAC shares currently have a short interest ratio of 6.0. Learn More on CureVac's short interest ratio. Which institutional investors are shorting CureVac? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CureVac: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for CureVac? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.79% of CureVac's floating shares are currently sold short. Is CureVac's short interest increasing or decreasing? CureVac saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 4,390,000 shares, an increase of 4.8% from the previous total of 4,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CureVac's float size? CureVac currently has issued a total of 223,880,000 shares. Some of CureVac's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CureVac currently has a public float of 91,600,000 shares. How does CureVac's short interest compare to its competitors? 4.79% of CureVac's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CureVac: AnaptysBio, Inc. (18.06%), Cogent Biosciences, Inc. (12.59%), GH Research PLC (5.05%), Wave Life Sciences Ltd. (2.27%), Calliditas Therapeutics AB (publ) (0.03%), Nuvation Bio Inc. (2.51%), Sage Therapeutics, Inc. (16.60%), Nurix Therapeutics, Inc. (14.04%), Phibro Animal Health Co. (2.76%), Pharming Group (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short CureVac stock? Short selling CVAC is an investing strategy that aims to generate trading profit from CureVac as its price is falling. CVAC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CureVac? A short squeeze for CureVac occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CVAC, which in turn drives the price of the stock up even further. How often is CureVac's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CVAC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AnaptysBio Short Squeeze Cogent Biosciences Short Squeeze GH Research Short Squeeze Wave Life Sciences Short Squeeze Calliditas Therapeutics AB (publ) Short Squeeze Nuvation Bio Short Squeeze Sage Therapeutics Short Squeeze Nurix Therapeutics Short Squeeze Phibro Animal Health Short Squeeze Pharming Group Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CVAC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics